Literature DB >> 24643184

Human papillomavirus and immunosuppression.

Ulrike Wieland1, Alexander Kreuter, Herbert Pfister.   

Abstract

Chronic immunosuppression for various reasons is an important risk factor for persistent infections with human papillomaviruses (HPV) and HPV-associated disease. Anogenital cancers and their precursor lesions play an important role in modern HIV medicine. Anal intraepithelial neoplasia and anal cancer are especially prevalent in HIV-positive men who have sex with men, and experts have advocated screening similarly to cervical cancer screening for this high-risk group. HPV-induced skin warts are a frequent problem of organ transplant recipients (OTRs) and a severe manifestation (generalized verrucosis) of certain primary immunodeficiencies. HIV-positive individuals are very often affected by genital warts (condylomata acuminata). Iatrogenic immunosuppression in OTRs allows more active replication of the commensal β-papillomavirus spectrum in the entire skin. A high viral DNA load in plucked eyebrow hairs was shown to imply a significant risk for the development of cutaneous squamous cell carcinoma. This may explain the up to 250-fold increased risk of OTRs to develop precancerous actinic keratoses and skin cancer.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 24643184     DOI: 10.1159/000357907

Source DB:  PubMed          Journal:  Curr Probl Dermatol        ISSN: 1421-5721


  25 in total

Review 1.  Beta genus papillomaviruses and skin cancer.

Authors:  Peter M Howley; Herbert J Pfister
Journal:  Virology       Date:  2015-02-24       Impact factor: 3.616

2.  Anal Cancer Risk Among People With HIV Infection in the United States.

Authors:  Vivian Colón-López; Meredith S Shiels; Mark Machin; Ana P Ortiz; Howard Strickler; Philip E Castle; Ruth M Pfeiffer; Eric A Engels
Journal:  J Clin Oncol       Date:  2017-11-15       Impact factor: 44.544

Review 3.  Opportunities and challenges for human papillomavirus vaccination in cancer.

Authors:  Richard B S Roden; Peter L Stern
Journal:  Nat Rev Cancer       Date:  2018-03-02       Impact factor: 60.716

Review 4.  Human genetic dissection of papillomavirus-driven diseases: new insight into their pathogenesis.

Authors:  Vivien Béziat
Journal:  Hum Genet       Date:  2020-05-20       Impact factor: 4.132

Review 5.  Human genetic and immunological dissection of papillomavirus-driven diseases: new insights into their pathogenesis.

Authors:  Vivien Béziat; Jean-Laurent Casanova; Emmanuelle Jouanguy
Journal:  Curr Opin Virol       Date:  2021-09-21       Impact factor: 7.090

6.  Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses.

Authors:  Somayeh Pouyanfard; Gloria Spagnoli; Lorenzo Bulli; Kathrin Balz; Fan Yang; Caroline Odenwald; Hanna Seitz; Filipe C Mariz; Angelo Bolchi; Simone Ottonello; Martin Müller
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

7.  Pathogenesis, diagnosis and therapeutic strategies in WHIM syndrome immunodeficiency.

Authors:  Lauren E Heusinkveld; Erin Yim; Alexander Yang; Ari B Azani; Qian Liu; Ji-Liang Gao; David H McDermott; Philip M Murphy
Journal:  Expert Opin Orphan Drugs       Date:  2017-09-25       Impact factor: 0.694

Review 8.  Human Papilloma Virus Infection and Anal Squamous Intraepithelial Lesions.

Authors:  Laura Svidler López; Luciana La Rosa
Journal:  Clin Colon Rectal Surg       Date:  2019-08-22

9.  Cutaneous beta human papillomaviruses and the development of male external genital lesions: A case-control study nested within the HIM Study.

Authors:  Christine M Pierce Campbell; Tarik Gheit; Massimo Tommasino; Hui-Yi Lin; B Nelson Torres; Jane L Messina; Mark H Stoler; Dana E Rollison; Bradley A Sirak; Martha Abrahamsen; Roberto J Carvalho da Silva; Laura Sichero; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano
Journal:  Virology       Date:  2016-08-10       Impact factor: 3.616

Review 10.  Viruses and Skin Cancer.

Authors:  Sara Becerril; Roberto Corchado-Cobos; Natalia García-Sancha; Leonor Revelles; David Revilla; Tatiana Ugalde; Concepción Román-Curto; Jesús Pérez-Losada; Javier Cañueto
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.